High-end pharmaceutical excipients also play an indispensable and crucial role in the modern pharmaceutical industry. It is by no means a simple auxiliary ingredient, but has a decisive influence on key properties such as the stability, solubility, release rate and bioavailability of the drug. For instance, in sustained-release and controlled-release preparations, high-end pharmaceutical excipients can precisely regulate the release rate and timing of drugs, ensuring that the drugs continuously and stably exert their effects in the body and significantly enhancing patients' medication compliance. In the field of injectables, high-quality pharmaceutical excipients can effectively ensure the clarity, stability and safety of drugs, and reduce the risk of adverse reactions. ​

With the rapid development of medical technology, new types of drug preparations such as liposomes, microspheres, and nanoparticles are constantly emerging. These high-end preparations have put forward almost strict requirements for the performance and quality of pharmaceutical excipients. The market demand for high-end pharmaceutical excipients has also witnessed explosive growth. The State Council clearly pointed out in the "Catalogue for the Guidance of Industrial Structure Adjustment (2024 Edition)" that it is necessary to vigorously develop supporting industries such as "the development and production of high-end pharmaceutical excipients and new adjuvants for vaccines", which undoubtedly injects a strong boost into the development of the high-end pharmaceutical excipients industry. ​

China's high-end pharmaceutical excipients industry started relatively late. For a long time in the past, domestic biopharmaceutical enterprises were highly dependent on imported pharmaceutical excipients. This not only increased the production costs of enterprises but also seriously restricted the independent and controllable development of China's pharmaceutical industry, greatly increasing the risk of being "strangled". However, in recent years, with the strong support of policies and the active efforts of enterprises, China's high-end pharmaceutical excipients industry has ushered in a golden period of rapid development. Domestic enterprises have increased their investment in research and development, strengthened technological innovation, and gradually narrowed the gap with the international advanced level. Some high-end pharmaceutical excipients have achieved domestic production and have emerged in the market. ​

Chuzhou Qingyun Pharmaceutical Co., Ltd. has keenly captured the huge potential of the high-end pharmaceutical excipients market and actively laid out in this field. Relying on advanced production equipment and a strict quality management system, the company is committed to the research and development and production of high-quality pharmaceutical excipients. Through continuous technological innovation and process improvement, the company's high-end pharmaceutical excipients have reached the level of international counterparts in terms of quality stability and performance superiority, providing reliable local options for domestic formulation enterprises and effectively promoting the development of China's high-end formulation industry.